Rein Therapeutics, Inc. · NASDAQ:RNTX
LYTTON LAURENCE W's stake in Rein Therapeutics, Inc. fell to 4.90% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
LYTTON LAURENCE W's stake in Rein Therapeutics, Inc. fell to 4.90%, 4,238,628 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 4.90%
- Shares
- 4,238,628
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| LYTTON LAURENCE W | 4.90% | 4,238,628 |
Source
Related
- Rein Therapeutics, Inc.
- Laurence W. Lytton
- Rein Therapeutics, Inc. shareholders
- Schedule 13G · Laurence W. Lytton · May 6, 2026
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026
- Form 4 · Windsor James Brian · May 13, 2026